Jpmorgan Chase & CO Aurinia Pharmaceuticals Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 507,034 shares of AUPH stock, worth $3.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

507,034

Previous 307,931 64.66%

Holding current value

$3.66 Million

Previous $1.54 Million 87.74%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$4.81 - $5.78 $957,685 - $1.15 Million	199,103 Added 64.66%	507,034 $2.9 Million
Q1 2024 May 10, 2024	BUY	$4.93 - $9.31 $437,922 - $826,988	88,828 Added 40.54%	307,931 $1.54 Million
Q4 2023 Feb 12, 2024	SELL	$7.13 - $9.49 $67,136 - $89,357	-9,416 Reduced 4.12%	219,103 $1.97 Million
Q3 2023 Nov 14, 2023	SELL	$7.77 - $12.27 $1.27 Million - $2.01 Million	-163,899 Reduced 41.77%	228,519 $1.78 Million
Q2 2023 Aug 11, 2023	BUY	$8.96 - $11.69 $1.62 Million - $2.11 Million	180,476 Added 85.15%	392,418 $3.8 Million
Q1 2023 May 18, 2023	BUY	$5.94 - $11.27 $1.02 Million - $1.94 Million	172,363 Added 435.49%	211,942 $2.32 Million
Q1 2023 May 11, 2023	SELL	$5.94 - $11.27 $602,500 - $1.14 Million	-101,431 Reduced 71.93%	39,579 $433,000
Q4 2022 Feb 13, 2023	BUY	$4.11 - $8.14 $268,983 - $532,730	65,446 Added 86.61%	141,010 $610,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $21,911 - $40,763	3,290 Added 4.55%	75,564 $568,000
Q2 2022 Aug 11, 2022	BUY	$8.95 - $12.8 $578,608 - $827,507	64,649 Added 847.86%	72,274 $726,000
Q1 2022 May 11, 2022	BUY	$10.05 - $22.48 $41,345 - $92,482	4,114 Added 117.17%	7,625 $94,000
Q4 2021 Feb 10, 2022	SELL	$17.78 - $33.08 $44,432 - $82,666	-2,499 Reduced 41.58%	3,511 $80,000
Q3 2021 Nov 12, 2021	BUY	$10.93 - $23.55 $65,689 - $141,535	6,010 New	6,010 $133,000

Others Institutions Holding AUPH

# of Institutions

190

Shares Held

56.5M

Call Options Held

499K

Put Options Held

637K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.02B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Aurinia Pharmaceuticals Inc. Transaction History